agree a takeover bid of $2.00 will be deemed too low. The recent popularity of discussion for a t/o reaffirms how very close MSB is to getting to commercialisation and the credibility it serves up to the FDA. I'm quietly confident Mesoblast will attract a partnership congruent to its objectives of delivering world class medical alternatives their journey I believe will come to fruition.
banter and General Discussion, page-9647
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $6.078M | 3.759M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 31734 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 880 | 4 |
View Market Depth
| Last trade - 15.12pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |